• 1
    Navasa M, Rimola A, Rodes J. Bacterial infection in liver disease. Semin Liver Dis 1997; 17:32333.
  • 2
    Christou L, Pappas G, Falagas ME. Bacterial infection related morbidity and mortality in cirrosis. Am J Gastroenterol 2007; 102:151017.
  • 3
    Gomez F, Ruiz P, Schreiber AD. Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N Engl J Med 1994; 331:11228.
  • 4
    Bolognesi M, Merkel C, Bianco S et al. Clinical significance of the evaluation of hepatic reticulo-endothelial removal capacity in patients with cirrhosis. Hepatology 1994; 19:62834.
  • 5
    Laso FJ, Madruga JI, Girón JA et al. Decreased natural killer cytotoxic activity in chronic alcoholism is associated with alcohol liver disease but not active ethanol consumption. Hepatology 1997; 25:1096100.
  • 6
    Girón JA, Alvarez-Mon M, Menéndez-Caro JL et al. T Lymphocytes from alcoholic cirrhotic patients show normal interleukin 2 production but a defective proliferative response to polyclonal mitogens. Am J Gastroenterol 1994; 89:76773.
  • 7
    Girón JA, Alvárez-Mon M, Menéndez-Caro JL et al. Increased spontaneous and lymphokine-conditioned immunoglobulin A and G synthesis by B cells from alcoholic cirrhotic patients. Hepatology 1992; 16:66470.
  • 8
    Menéndez JL, Alvarez-Mon M, Girón JA et al. IgM B cell differentiation production by T lymphocytes from patients with primary biliary cirrhosis. J Hepatol 1994; 20:44653.
  • 9
    Wiest R, Das S, Cadelina G, García-Tsao G, Milstien S, Groszman RJ. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest 1999; 104:122333.
  • 10
    Zapater P, Francés R, González-Navajas JM et al. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in non-infected patients with cirrhosis. Hepatology 2008; 48:192431.
  • 11
    Schumann RR, Zweigner J. A novel acute-phase marker: lipopolysaccharide binding protein (LBP). Clin Chem Lab Med 1999; 37:2714.
  • 12
    Albillos A, De La Hera A, González M et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003; 37:20817.
  • 13
    Genesca J, Marti R, Rojo F et al. Increased tumor necrosis factor-α production in mesenteric lymph nodes of cirrhotic patients with ascites. Gut 2003; 52:10549.
  • 14
    Girón-González JA, Martínez-Sierra C, Rodriguez-Ramos C et al. Implication of inflammation-related cytokines in the natural history of liver cirrhosis. Liver Int 2004; 24:43745.
  • 15
    Albillos A, De La Hera A, Reyes E et al. Tumour necrosis factor-alpha expression by altered monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin. J Hepatol 2004; 40:62431.
  • 16
    Albillos A, De La Hera A, Alvarez-Mon M. Serum lipopolysaccharide binding-protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet 2004; 363:160810.
  • 17
    Hopkins PA, Fraser JD, Pridmore AC, Russell HH, Read RC, Sriskandan S. Superantigen recognition by HLA class II on monocytes up-regulates Toll-like receptor 4 and enhances proinflammatory responses to endotoxin. Blood 2005; 105:365562.
  • 18
    Sriskandan S, Altmann D. The immunology of sepsis. J Pathol 2008; 214:21123.
  • 19
    Smith KA. Interleukin-2: inception, impact, and implications. Science 1988; 240:116976.
  • 20
    Brenchley JM, Karandikar NJ, Betts MR et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003; 101:271120.
  • 21
    Bernard A, Lamy LA, Alberti I. The two-signal model of T-cell activation after 30 years. Transplantation 2002; 73:S31S35.
  • 22
    Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for co-stimulation and inhibition of immune responses. Annu Rev Immunol 2002; 20:2953.
  • 23
    Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FoxP3. Science 2003; 299:105761.
  • 24
    Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19:151320.
  • 25
    Tchelepi H, Ralls PW, Radin R, Grant E. Sonography of diffuse liver disease. J Ultrasound Med 2002; 21:102332.
  • 26
    Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:6469.
  • 27
    Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:46470.
  • 28
    Porteu F, Nathan C. Shedding of tumor necrosis factor receptors by activated human neutrophils. J Exp Med 1990; 172:599607.
  • 29
    Deviere J, Content J, Denys C et al. Excessive in vitro bacterial lipopolysaccharide-induced production on monokines in cirrhosis. Hepatology 1990; 11:62834.
  • 30
    Lavrik I, Golks A, Krammer PH. Death receptor signalling. J Cell Sci 2005; 118:2657.
  • 31
    Green DR, Droin N, Pinkoski M. Activation-induced cell death in T cells. Immunol Rev 2003; 193:7081.
  • 32
    Brenner D, Krammer PH, Arnold R. Concepts of activated T cell death. Crit Rev Oncol Hematol 2008; 66:5264.
  • 33
    Marinova E, Han S, Zheng B. Human germinal center T cells are unique T cells with high propensity for apoptosis induction. Int Immunol 2006; 18:133745.
  • 34
    Tarazona R, De la Rosa O, Alonso C et al. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev 2000; 121:7788.
  • 35
    Brunner-Weinzierl MC, Hoff H, Burmester GR. Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseases. Arthritis Res Ther 2004; 6:4554.
  • 36
    Mattern T, Flad HD, Brade L, Rietschel ET, Ulmer AJ. Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions. J Immunol 1998; 160:341218.
  • 37
    Medzhitov R, Janeway C. Innate immunity. N Engl J Med 2000; 343:33844.
  • 38
    Bluestone JA, Abbas AK. Natural versus adaptive regulatory T cells. Nat Rev Immunol 2003; 3:2537.
  • 39
    Cederbom L, Hall H, Ivars F. CD4+CD25+ regulatory T cells downregulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 2000; 30:153843.
  • 40
    Stassen M, Schmitt E, Jonuleit H. Human CD4+CD25+ regulatory T cells and infectious tolerance. Transplantation 2004; 77 (Suppl.):S235.
  • 41
    Cabrera R, Tu Z, Xu Y et al. An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004; 40:106271.
  • 42
    Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002; 420:5027.
  • 43
    Roth P, Bartocci A, Stanley ER. Lipopolysaccharide induces synthesis of mouse colony-stimulating factor-1 in vivo. J Immunol 1997; 158:387480.
  • 44
    Kanto T, Hayashi N. Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptative immunity. Intern Med 2006; 45:18391.
  • 45
    Laso FJ, Vaquero JM, Almeida J, Marcos M, Orfao A. Chronic alcohol consumption is associated with changes in the distribution, immunophenotype, and the inflammatory cytokine secretion profile of circulating dendritic cells. Alcohol Clin Exp Res 2007; 31:84654.
  • 46
    Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev 2000; 174:520.
  • 47
    Eksteen B, Afford SC, Wigmore SJ, Holt AP, Adams DH. Immune-mediated liver injury. Semin Liver Dis 2007; 27:35166.
  • 48
    Unutmaz D, Pileri P, Abrignani S. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Exp Med 1994; 180:115964.